国际领先心脏冷冻消融系统在沈抚示范区下线

Core Insights - The first unit of the cardiac cryoablation system developed by Shenyang Pengyue Technology Co., Ltd. has been officially launched, marking a significant advancement in the treatment of persistent atrial fibrillation in adult heart disease patients [1] - This innovative medical device is the first of its kind internationally to feature active rewarming, vacuum insulation, and backside temperature feedback technologies, filling a gap in the domestic high-end medical equipment sector and breaking the technological monopoly of foreign manufacturers in the field of surgical treatment for atrial fibrillation [1] Company Developments - The Pengyue Technology cryoablation system has received approval from the National Medical Products Administration for innovative medical device registration, enabling precise ablation of myocardial cells while maximizing the protection of myocardial fiber skeletons and surrounding nerve blood vessels [1] - The product is seen as a benchmark achievement in promoting the deep integration of technological innovation and industrial innovation within the Shenyang-Fushun Reform and Innovation Demonstration Zone, contributing to the development of a low-temperature cryogenic medical industry chain [1] Industry Impact - The introduction of this product is expected to demonstrate significant value in promoting the high-end and clustered development of strategic emerging industries [1]